Rat-study gives new hope to Parkinson’s patients
A small Danish biotech company has been granted millions from SEED Capital and Novo Seeds for a new study.
Following successful studies with rats, the small Danish biotech Company, Concit Pharma, is now trying to find the solution to a highly debilitating side-effect from the medical treatment of Parkinson’s patients. The solution is to be found in the combination of existing drugs and two major investors are ready with capital injection, the company reveals in a press release.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
